purixan

Generic: purixan

Labeler: nova laboratories, ltd
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name purixan
Generic Name purixan
Labeler nova laboratories, ltd
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

mercaptopurine 20 mg/mL

Manufacturer
Nova Laboratories, Ltd

Identifiers & Regulatory

Product NDC 62484-0020
Product ID 62484-0020_3f47ad32-2ec4-477b-89a0-d2cd2b686373
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA205919
Listing Expiration 2026-12-31
Marketing Start 2014-04-28

Pharmacologic Class

Classes
nucleic acid synthesis inhibitors [moa] nucleoside metabolic inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 624840020
Hyphenated Format 62484-0020

Supplemental Identifiers

RxCUI
1536484 1536490
UPC
0362484002018
UNII
E7WED276I5

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name purixan (source: ndc)
Generic Name purixan (source: ndc)
Application Number NDA205919 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1)
source: ndc

Packages (1)

Ingredients (1)

mercaptopurine (20 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3f47ad32-2ec4-477b-89a0-d2cd2b686373", "openfda": {"upc": ["0362484002018"], "unii": ["E7WED276I5"], "rxcui": ["1536484", "1536490"], "spl_set_id": ["9fd27952-7787-47d9-b6cf-7af2dc38217b"], "manufacturer_name": ["Nova Laboratories, Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (62484-0020-2)  / 100 mL in 1 BOTTLE (62484-0020-1)", "package_ndc": "62484-0020-2", "marketing_start_date": "20140428"}], "brand_name": "PURIXAN", "product_id": "62484-0020_3f47ad32-2ec4-477b-89a0-d2cd2b686373", "dosage_form": "SUSPENSION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "62484-0020", "generic_name": "Purixan", "labeler_name": "Nova Laboratories, Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PURIXAN", "active_ingredients": [{"name": "MERCAPTOPURINE", "strength": "20 mg/mL"}], "application_number": "NDA205919", "marketing_category": "NDA", "marketing_start_date": "20140428", "listing_expiration_date": "20261231"}